Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Lithia Motors enters its October 21 earnings date under coordinated analyst pressure, with four major firms cutting price targets in the past week alone, even as the stock trades at a steep discount to where most of the Street still sees fair value.
The Street's message this week has been unambiguous: expectations are coming down. UBS cut its target from $440 to $335 on October 7, keeping a Neutral rating. JP Morgan trimmed from $340 to $320 a day earlier, also at Neutral. Barclays lowered from $415 to $375 while holding its Overweight. Morgan Stanley moved from $358 to $310 at Equal-Weight. That is four firms, four cuts, across a single three-day window. The mean target across the analyst group is now $433, which implies roughly 48% upside from the current $292.51 close. That gap reflects how far the stock has fallen in a month, down 24%, rather than a sudden surge in analyst bullishness. The cuts follow a pattern: target resets after the stock has already moved, not ahead of it. Citigroup's Buy-rated analyst moved from $455 to $409 in late September, and Barclays had only raised to $415 in August before reversing this week. The direction of travel is clear, even if most ratings have held.
Short interest does not tell an especially alarming story given all the pressure, but it is worth noting where it has been. At 7.3% of free float, it is a meaningful level, though the position has been unwinding steadily since early September, when it briefly pushed above 9% of float. Over the past month it has fallen 13.6%, and the weekly change is essentially flat, up just 0.2%. The borrow market backs this up: availability is very loose at around 518%, meaning there are more than five shares available to borrow for every one already borrowed. Cost to borrow is at 0.44%, effectively at the floor. Shorts are not scrambling in either direction; the move lower in September came and went, and the current level looks settled rather than building.
Options positioning tells an unusual story. The put/call ratio is running at 6.54, essentially in line with its 20-day average of 6.53 and well within normal range, with a z-score near zero. At first glance that sounds calm, but a PCR above 6 sustained for weeks is itself structurally defensive. The 52-week low is 0.57, so the current level reflects a market where put protection has been dominant for an extended period. The ratio peaked at 7.07 in late September as the stock was falling hardest, and has eased slightly since. The picture is one of entrenched caution rather than any fresh spike.
One institutional detail worth flagging: Abrams Capital Management holds 11.3% of shares and has not changed its position, according to the most recent data. Harris Associates holds another 8.7%, also unchanged. FMR (Fidelity) added 217,695 shares through July, bringing its stake to 9%. The top of the register is concentrated and, at least through mid-year, was not reducing. Dimensional Fund Advisors bumped its position slightly to 6.4% as recently as September 30. None of this reads as institutional flight, though reporting lags mean Q3 data is only now coming through.
Valuation at the current price is genuinely low. The P/E has compressed to 7.2 and the price-to-book is below 1 at 0.89, with EV/EBITDA at 12.5. The 30-day move in PB is down 0.30 points, tracking the stock's drop. Factor scores show the stock ranks in the 80th percentile on forward EPS growth and the 80th on earnings surprise, but only the 18th on short score rank, reflecting residual short positioning relative to peers. Retail attention has picked up, with a Wikipedia-views z-score of 2.15 against the prior 90-day average as of late September, likely a function of the sharp price move drawing casual interest.
The last earnings print, on July 29, produced a 13% single-day gain. With the next report due October 21, fourteen days away, the setup is the inverse of that moment: the stock is down 24% over the past month, targets have just been cut by every major firm covering it, and the mean analyst target still implies a large gap to current levels. Whether that gap closes from the stock moving up or from targets continuing to fall is what the October 21 print will start to answer.
See the live data behind this article on ORTEX.
Open LAD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.